{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T18:28:45Z","timestamp":1785176925486,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005031","name":"Bhabha Atomic Research Centre","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005031","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s10096-025-05221-6","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T10:32:43Z","timestamp":1753785163000},"page":"2645-2654","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rapid screening of mutations for second-line-drug-resistant genes in Mycobacterium tuberculosis culture isolates by in-house developed DNA bio-chip"],"prefix":"10.1007","volume":"44","author":[{"given":"Bharti","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savita","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawab Singh","family":"Baghel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"5221_CR1","unstructured":"Global Tuberculosis Report (2024) World Health Organization 2024"},{"key":"5221_CR2","doi-asserted-by":"publisher","first-page":"100155","DOI":"10.1016\/j.jctube.2020.100155","volume":"19","author":"A Bhargava","year":"2020","unstructured":"Bhargava A, Bhargava M (2020) Tuberculosis deaths are predictable and preventable: comprehensive assessment and clinical care is the key. J Clin Tuberc Other Mycobact Dis 19:100155","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"5221_CR3","unstructured":"Global Tuberculosis Report (2022) World Health Organization 2022 https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2022"},{"key":"5221_CR4","unstructured":"WHO\u2019s (2019) Global tuberculosis report 2019. WHO\/CDS\/TB\/201915"},{"key":"5221_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ijid.2023.04.392","volume":"132","author":"G Diriba","year":"2023","unstructured":"Diriba G, Alemu A, Yenew B, Tola HH, Gamtesa DF, Mollalign H et al (2023) Epidemiology of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a systematic review and meta-analysis. Int J Infect Dis 132:50\u201363","journal-title":"Int J Infect Dis"},{"key":"5221_CR6","unstructured":"Organization WH (2014) Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. World Health Organization"},{"issue":"6","key":"5221_CR7","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1128\/jcm.00051-16","volume":"54","author":"F Brossier","year":"2016","unstructured":"Brossier F, Guindo D, Pham A, Reibel F, Sougakoff W, Veziris N et al (2016) Performance of the new version (v2. 0) of the genotype MTBDR Sl test for detection of resistance to second-line drugs in multidrug-resistant Mycobacterium tuberculosis complex strains. J Clin Microbiol 54(6):1573\u20131580. https:\/\/doi.org\/10.1128\/jcm.00051-16","journal-title":"J Clin Microbiol"},{"key":"5221_CR8","unstructured":"Organization WH (2016) The use of molecular line probe assays for the detection of resistance to second-line anti-tuberculosis drugs: policy guidance. World Health Organization"},{"issue":"8","key":"5221_CR9","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1128\/AAC.39.8.1700","volume":"39","author":"GJ Alangaden","year":"1995","unstructured":"Alangaden GJ, Manavathu EK, Vakulenko SB, Zvonok NM, Lerner SA (1995) Characterization of fluoroquinolone-resistant mutant strains of Mycobacterium tuberculosis selected in the laboratory and isolated from patients. Antimicrob Agents Chemother 39(8):1700\u20131703","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"5221_CR10","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S1473-3099(03)00671-6","volume":"3","author":"AS Ginsburg","year":"2003","unstructured":"Ginsburg AS, Grosset JH, Bishai WR (2003) Fluoroquinolones, tuberculosis, and resistance. Lancet Infect Dis 3(7):432\u2013442","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"5221_CR11","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1128\/AAC.42.8.2084","volume":"42","author":"I Guillemin","year":"1998","unstructured":"Guillemin I, Jarlier V, Cambau E (1998) Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria. Antimicrob Agents Chemother 42(8):2084\u20132088","journal-title":"Antimicrob Agents Chemother"},{"key":"5221_CR12","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.3389\/fmicb.2019.01838","volume":"10","author":"Q Li","year":"2019","unstructured":"Li Q, Gao H, Zhang Z, Tian Y, Liu T, Wang Y et al (2019) Mutation and transmission profiles of second-line drug resistance in clinical isolates of drug-resistant Mycobacterium tuberculosis from Hebei province, China. Front Microbiol 10:1838","journal-title":"Front Microbiol"},{"issue":"4","key":"5221_CR13","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/jac\/dkr566","volume":"67","author":"F Maruri","year":"2012","unstructured":"Maruri F, Sterling TR, Kaiga AW, Blackman A, van der Heijden YF, Mayer C et al (2012) A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system. J Antimicrob Chemother 67(4):819\u2013831","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"5221_CR14","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1128\/AAC.49.8.3192-3197.2005","volume":"49","author":"CE Maus","year":"2005","unstructured":"Maus CE, Plikaytis BB, Shinnick TM (2005) Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother 49(8):3192\u20133197","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"5221_CR15","doi-asserted-by":"publisher","first-page":"e02075","DOI":"10.1128\/aac.02075-21","volume":"66","author":"D Conkle-Gutierrez","year":"2022","unstructured":"Conkle-Gutierrez D, Kim C, Ramirez-Busby SM, Modlin SJ, Mansj\u00f6 M, Werngren J et al (2022) Distribution of common and rare genetic markers of second-line-Injectable-drug resistance in Mycobacterium tuberculosis revealed by a genome-wide association study. Antimicrob Agents Chemother 66(6):e02075\u2013e02021. https:\/\/doi.org\/10.1128\/aac.02075-21","journal-title":"Antimicrob Agents Chemother"},{"key":"5221_CR16","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1590\/S1678-9946202163019","volume":"63","author":"G Momen","year":"2021","unstructured":"Momen G, Aainouss A, Lamaammal A, Chettioui F, Blaghen M, Messoudi M et al (2021) Molecular characterization of mutations associated with resistance to second line drugs in Mycobacterium tuberculosis patients from casablanca, Morocco. Rev Inst Med Trop Sao Paulo 63:e19. https:\/\/doi.org\/10.1590\/S1678-9946202163019","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"5221_CR17","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s11274-013-1256-x","volume":"29","author":"HN Jnawali","year":"2013","unstructured":"Jnawali HN, Yoo H, Ryoo S, Lee K-J, Kim B-J, Koh W-J et al (2013) Molecular genetics of Mycobacterium tuberculosis resistant to aminoglycosides and Cyclic peptide capreomycin antibiotics in Korea. World J Microbiol Biotechnol 29:975\u2013982","journal-title":"World J Microbiol Biotechnol"},{"issue":"3","key":"5221_CR18","doi-asserted-by":"publisher","first-page":"e0229419","DOI":"10.1371\/journal.pone.0229419","volume":"15","author":"SB Rufai","year":"2020","unstructured":"Rufai SB, Umay K, Singh PK, Singh S (2020) Performance of genotype MTBDR Sl V2. 0 over the genotype MTBDR Sl V1 for detection of second line drug resistance: an Indian perspective. PLoS ONE 15(3):e0229419","journal-title":"PLoS ONE"},{"issue":"3\u20134","key":"5221_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.tube.2004.01.002","volume":"84","author":"PD Butcher","year":"2004","unstructured":"Butcher PD (2004) Microarrays for Mycobacterium tuberculosis. Tuberculosis (Edinb) 84(3\u20134):131\u2013137","journal-title":"Tuberculosis (Edinb)"},{"issue":"6","key":"5221_CR20","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1093\/jac\/dkw015","volume":"71","author":"DV Zimenkov","year":"2016","unstructured":"Zimenkov DV, Kulagina EV, Antonova OV, Zhuravlev VY, Gryadunov DA (2016) Simultaneous drug resistance detection and genotyping of Mycobacterium tuberculosis using a low-density hydrogel microarray. J Antimicrob Chemother 71(6):1520\u20131531. https:\/\/doi.org\/10.1093\/jac\/dkw015","journal-title":"J Antimicrob Chemother"},{"key":"5221_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-13-240","volume":"13","author":"DV Zimenkov","year":"2013","unstructured":"Zimenkov DV, Antonova OV, Kuz\u2019min AV, Isaeva YD, Krylova LY, Popov SA et al (2013) Detection of second-line drug resistance in Mycobacterium tuberculosis using oligonucleotide microarrays. BMC Infect Dis 13:1\u20138","journal-title":"BMC Infect Dis"},{"issue":"3","key":"5221_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1080\/15321819.2016.1250771","volume":"38","author":"B Jain","year":"2017","unstructured":"Jain B, Kumarasamy J, Gholve C, Kulkarni S, Rajan M (2017) A multi-analyte immunoassay for thyroid related analytes. J Immunoass Immunochem 38(3):271\u2013284. https:\/\/doi.org\/10.1080\/15321819.2016.1250771","journal-title":"J Immunoass Immunochem"},{"issue":"2","key":"5221_CR23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12291-016-0589-2","volume":"32","author":"B Jain","year":"2017","unstructured":"Jain B, Kumarasamy J, Gholve C, Kulkarni S, Rajan M (2017) A microarray immunoassay for serum Thyrotropin and thyroglobulin using antibodies immobilized on track-etched membranes. Indian J Clin Biochem 32(2):193\u2013199. https:\/\/doi.org\/10.1007\/s12291-016-0589-2","journal-title":"Indian J Clin Biochem"},{"issue":"1\u20132","key":"5221_CR24","first-page":"65","volume":"54","author":"B Jain","year":"2018","unstructured":"Jain B, Kulkarni S, Rajan M (2018) Radiometric multiplexed immunoassay for the simultaneous detection of thyroxine and thyroid stimulating hormone in serum samples. Indian J Biochem Biophys 54(1\u20132):65\u201370","journal-title":"Indian J Biochem Biophys"},{"key":"5221_CR25","doi-asserted-by":"publisher","unstructured":"Jain B, Kulkarni S Development of DNA Bio-chip for detection of mutations of rpob, embb and InhA genes in Drug-Resistant Mycobacterium Tuberculosis. Indian J Clin Biochem 2022:1\u20139. https:\/\/doi.org\/10.1007\/s12291-022-01044-w","DOI":"10.1007\/s12291-022-01044-w"},{"issue":"1","key":"5221_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12088-023-01116-2","volume":"64","author":"B Jain","year":"2024","unstructured":"Jain B, Kulkarni S (2024) Molecular detection of multidrug resistance and characterizations of mutations in Mycobacterium Tuberculosis using polycarbonate Track-Etched membrane based DNA Bio-Chip. Indian J Microbiol 64(1):92\u201399","journal-title":"Indian J Microbiol"},{"issue":"11","key":"5221_CR27","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1128\/jcm.29.11.2578-2586","volume":"29","author":"D Van Soolingen","year":"1991","unstructured":"Van Soolingen D, Hermans P, De Haas P, Soll D, Van Embden J (1991) Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J Clin Microbiol 29(11):2578\u20132586. https:\/\/doi.org\/10.1128\/jcm.29.11.2578-2586","journal-title":"J Clin Microbiol"},{"issue":"2","key":"5221_CR28","doi-asserted-by":"publisher","first-page":"e1536","DOI":"10.1371\/journal.pone.0001536","volume":"3","author":"DI Ling","year":"2008","unstructured":"Ling DI, Flores LL, Riley LW, Pai M (2008) Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression. PLoS ONE 3(2):e1536","journal-title":"PLoS ONE"},{"issue":"2","key":"5221_CR29","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3390\/clinpract14020030","volume":"14","author":"N Zaporojan","year":"2024","unstructured":"Zaporojan N, Negrean RA, Hodi\u0219an R, Zaporojan C, Csep A, Zaha DC (2024) Evolution of laboratory diagnosis of tuberculosis. Clin Pract 14(2):388\u2013416. https:\/\/doi.org\/10.3390\/clinpract14020030","journal-title":"Clin Pract"},{"issue":"1","key":"5221_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S1473-3099(17)30691-6","volume":"18","author":"SE Dorman","year":"2018","unstructured":"Dorman SE, Schumacher SG, Alland D, Nabeta P, Armstrong DT, King B et al (2018) Xpert MTB\/RIF ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis 18(1):76\u201384","journal-title":"Lancet Infect Dis"},{"key":"5221_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-12-303","volume":"12","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Li L, Luo F, Cheng P, Wu F, Wu Z et al (2012) Rapid and accurate detection of RMP-and INH-resistant Mycobacterium tuberculosis in spinal tuberculosis specimens by capitalbio\u2122 DNA microarray: A prospective validation study. BMC Infect Dis 12:1\u20137","journal-title":"BMC Infect Dis"},{"issue":"9","key":"5221_CR32","doi-asserted-by":"publisher","first-page":"O542","DOI":"10.1111\/1469-0691.12517","volume":"20","author":"W-L Huang","year":"2014","unstructured":"Huang W-L, Hsu Z-J, Chang T, Jou R (2014) Rapid and accurate detection of Rifampin and isoniazid-resistant Mycobacterium tuberculosis using an oligonucleotide array. Clin Microbiol Infect 20(9):O542\u2013O9","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"5221_CR33","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1128\/JCM.00439-06","volume":"44","author":"JC Caoili","year":"2006","unstructured":"Caoili JC, Mayorova A, Sikes D, Hickman L, Plikaytis BB, Shinnick TM (2006) Evaluation of the TB-Biochip oligonucleotide microarray system for rapid detection of Rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol 44(7):2378\u20132381","journal-title":"J Clin Microbiol"},{"issue":"11","key":"5221_CR34","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1128\/JCM.01958-12","volume":"50","author":"M Barnard","year":"2012","unstructured":"Barnard M, Gey van Pittius N, Van Helden P, Bosman M, Coetzee G, Warren R (2012) The diagnostic performance of the genotype MTBDR plus version 2 line probe assay is equivalent to that of the Xpert MTB\/RIF assay. J Clin Microbiol 50(11):3712\u20133716","journal-title":"J Clin Microbiol"},{"key":"5221_CR35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijid.2016.12.010","volume":"56","author":"EA Kendall","year":"2017","unstructured":"Kendall EA, Cohen T, Mitnick CD, Dowdy DW (2017) Second line drug susceptibility testing to inform the treatment of rifampin-resistant tuberculosis: a quantitative perspective. Int J Infect Dis 56:185\u2013189","journal-title":"Int J Infect Dis"},{"key":"5221_CR36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2165\/11595340-000000000-00000","volume":"30","author":"C Fitzpatrick","year":"2012","unstructured":"Fitzpatrick C, Floyd K (2012) A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosis. PharmacoEconomics 30:63\u201380","journal-title":"PharmacoEconomics"},{"key":"5221_CR37","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3389\/fmicb.2019.00794","volume":"10","author":"TNA Nguyen","year":"2019","unstructured":"Nguyen TNA, Berre A-L, Ba\u00f1uls A-L, Nguyen TVA (2019) Molecular diagnosis of drug-resistant tuberculosis; a literature review. Front Microbiol 10:794","journal-title":"Front Microbiol"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05221-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05221-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05221-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:02:30Z","timestamp":1763413350000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05221-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["5221"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05221-6","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}